NeuroMetrix Correlations
| NURODelisted Stock | USD 4.58 0.22 5.05% |
The current 90-days correlation between NeuroMetrix and QT Imaging Holdings is 0.22 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
NeuroMetrix Correlation With Market
Modest diversification
The correlation between NeuroMetrix and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeuroMetrix and DJI in the same portfolio, assuming nothing else is changed.
NeuroMetrix |
Moving against NeuroMetrix Stock
| 0.44 | ORGN | Origin Materials Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NeuroMetrix Stock performing well and NeuroMetrix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeuroMetrix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| QTI | 9.38 | 1.55 | 0.11 | (1.08) | 9.85 | 25.00 | 56.57 | |||
| FTRP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OSA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CNTG | 13.75 | 4.30 | 0.12 | 2.24 | 14.52 | 21.43 | 305.21 | |||
| CJJD | 3.63 | (0.31) | 0.00 | 0.56 | 0.00 | 5.56 | 33.93 | |||
| ETAO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| APGN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CRVO | 3.56 | (0.58) | 0.00 | (1.06) | 0.00 | 6.84 | 22.71 | |||
| TNFA | 8.70 | (0.57) | 0.00 | 0.59 | 0.00 | 17.75 | 79.44 |
NeuroMetrix Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeuroMetrix stock to make a market-neutral strategy. Peer analysis of NeuroMetrix could also be used in its relative valuation, which is a method of valuing NeuroMetrix by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
NeuroMetrix Corporate Executives
Elected by the shareholders, the NeuroMetrix's board of directors comprises two types of representatives: NeuroMetrix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NeuroMetrix. The board's role is to monitor NeuroMetrix's management team and ensure that shareholders' interests are well served. NeuroMetrix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NeuroMetrix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Higgins | CFO, Principal Accounting Officer, Sr. VP and Treasurer | Profile |
Still Interested in NeuroMetrix?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.